|
Market Cap (26-Jun) $2,171,520 (1,098th) |
Close (30-Jun) $0.021 |
Volume (30-Jun) 0 |
Shortsold (26-Jun) - |
|
52w High $0.021 |
52w Low $0.010 |
P/E - |
EPS -0.01 |
HXL released this announcement to the ASX on 26 July 2021, 10:58. The announcement is not marked as price sensitive, and is 3 page(s) in length and 206.4kb in size.
You can view all announcements from HXL and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from HXL | |
|---|---|
| Notice of change of interests of substantial holder | 26 June 2023, 8:16 |
| Notice of change of interests of substantial holder | 13 June 2023, 8:24 |
| Notice of change of interests of substantial holder | 8 June 2023, 8:16 |
| Completion of enrolment in Phase IIb Clinical Trial | 26 July 2021, 10:58 |
| Presenting Clinical Data at APMA and Investor Webinar | 15 July 2021, 11:12 |
| Grant of European Patent over Pezadeftide | 14 July 2021, 9:14 |
| Media Interview and Investor Presentation | 30 June 2021, 11:48 |
You must be logged in to post a reply.
